Advancing Topical Retinal Drug Delivery to Reduce Treatment Burden & Expand Global Access
2:30 pm - Thursday 21st January 2027
- Understand how to overcome the biological barriers that have historically limited topical drug delivery to the retina and unlock new opportunities for non-invasive treatment
- Explore formulation strategies that improve retinal penetration and therapeutic activity while maintaining ocular safety and tolerability, and enable convenient dosing to enhance adherence and long-term treatment success
- Learn how next-generation topical therapies could reduce reliance on intravitreal injections while expanding access to retinal disease treatment for underserved patient populations worldwide
